Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Formulation
9 million people develop diabetes, which is strongly associated with this risk factor!2023-01-12
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials2023-01-12
When the most prevalent mutant strain in the United States, it was detected in China2023-01-12
2022 FDA approval of new drug transcript2023-01-12
Qilu Pharmaceuticals "Ertapeneem Sodium for Injection" was approved for marketing the first to pass the consistency evaluation2023-01-12
The State Food Drug Administration accepted the marketing application of Ditze Pharma suvortinib2023-01-12
The global number of new crown sequelae is estimated to be nearly 145 million, we must be vigilant against these "new crown sequelae" after "Yangkang"!2023-01-06
Nicolas Pharmaceutical, the life death bureau of innovative drug patents2023-01-06
Domestic anti-HIV new drug, Addison Pharmaceuticals "Inomitine Tablets" was approved for marketing!2023-01-06
Medical insurance negotiation prospect: sky-high drugs, Paxlovid waiting for "turning positive", PD-(L)1 once again chasing the deer...2023-01-06
Deqi Pharmaceutical Merck reached a global clinical cooperation2022-12-29
Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca2022-12-15
Lilly gave up the overseas rights interests of Cindilimab, Cinda PD-1 had difficulty going to sea?2022-12-12
Global Vaccine Market Rises to the TopAgain2022-11-17
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA2022-11-17
he worlds first! RSV prevention therapy for infants young children was approved, the tens of billions of market ushered in a competitive battle2022-11-17
Fastest Times="32" billion ADC drug? Who can fight Enhertu for Breast cancer?2022-11-09
Pfizers paxlovid reduces the risk of COVID-19 by 26%2022-11-09
The battle between Pfizer Gilead over COVID-19 drugs will continue2022-11-04
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease2022-11-02
With a $10 billion market a clinical shortage, the first "Snoring medicine" is expected to hit the market2022-11-02
FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Discovery?2022-11-02
More than 40 products into the clinical! Claudin18.2 Target, who will dominate?2022-11-02
The worlds first Upadatinib extended-release tablets approved by FDA for non-radiological axial spondyloarthritis2022-11-02
JAK inhibitor, the successor to Hummero?2022-11-02
India starts testing a pharmaceuticalcompanys exports of cough syrup2022-10-24
New regulations on online sales of drugs clarify the management of online sales of prescription drugs2022-10-20
Flu new drug approved only 1 year, Shi Yao Ou Yi that is the first copy! Roche responds...2022-10-20
A quarter of a billion dollars! Merck Partners with Moderna to Advance mRNA cancer Vaccine plus K drug for melanoma2022-10-20
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy2022-10-20
When is "water inverse" going on? Biogens ALS drug approval delayed to next April2022-10-20
Not as good as a placebo? Relmada Therapeutics Shares plunge 80% after Phase 3 trial of New Drug for Major Depression fails!2022-10-20
1435个 页次:1/4532个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China